title: Retinopathy of prematurity in Bangladeshi neonates.
abstract: BACKGROUND
  Retinopathy of prematurity (ROP) is a potentially blinding eye disorder that primarily affects premature infants. Increased survival of extremely low birth weight infants following advances in antenatal and neonatal care has resulted in a population of infants at high risk of developing ROP. Long term morbidity of ROP has a spectrum ranging from myopia to blindness. Screening programs and early intervention can provide enormous economic and social benefits.
  
  
  METHODS
  Preterm infants of gestational age <33 weeks admitted to the Special Care Nursery of Dhaka Shishu Hospital for a trial of topical emollient therapy during December 1998-July 2003 were followed-up after hospital discharge, including detailed ophthalmologic examination. Detailed history regarding risks during pregnancy, delivery and hospital stay was documented. ROP cases were managed according to the stage of the disease at diagnosis.
  
  
  RESULTS
  Five out of the 114 (4.4%) children seen in follow-up were diagnosed with ROP. Low gestational age, low birth weight, administration of oxygen, apneic spells, sepsis and blood transfusions were common factors among cases who developed ROP.
  
  
  CONCLUSIONS
  As survival of preterm infants in low resource settings increases, ROP will become increasingly important as a potential cause of blindness, emphasizing the critical need for ophthalmologic examination in premature infants, with immediate initiation of treatment when ROP is diagnosed.
authors.affiliation: Department of Neonatology, Dhaka Shishu Children's Hospital, Dhaka, Bangladesh.
authors.forename: A S M Nawshad Uddin
authors.initials: AS
authors.lastname: Ahmed
authors.forename: Humaira
authors.initials: H
authors.lastname: Muslima
authors.forename: Kazi Shabbir
authors.initials: KS
authors.lastname: Anwar
authors.forename: Naila Z
authors.initials: NZ
authors.lastname: Khan
authors.forename: M A K Azad
authors.initials: MA
authors.lastname: Chowdhury
authors.forename: Samir K
authors.initials: SK
authors.lastname: Saha
authors.forename: Gary L
authors.initials: GL
authors.lastname: Darmstadt
mesh_terms: D001459:Bangladesh / Q000453:epidemiology; D001766:Blindness / Q000517:prevention & control; D004643:Emollients / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D005865:Gestational Age; D006801:Humans; D052577:Infant, Extremely Low Birth Weight; D007231:Infant, Newborn; D019102:Infant, Very Low Birth Weight; D008297:Male; D015997:Neonatal Screening; D009883:Ophthalmic Solutions; D012178:Retinopathy of Prematurity / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D012189:Retrospective Studies; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D004643:Emollients; D009883:Ophthalmic Solutions